dsips Home Pexip Awarded Contract Extension with

Speeds recovery

The FDA's Pharmacy Compounding Advisory Committee (PCAC) met July 2324 to evaluate whether certain peptides, including KPV, should be placed on the 503A Bulks List, which is the FDAs roster of substances eligible for pharmaceutical compounding

R2 R3 hexanoyl Tyr He pb heptanoyl Tyr He Pb pentanoyl Tyr He pb butanoyl Tyr He pb propanoyl Tyr He pb acetanoyl Tyr He pb benzoyl Tyr He pb hexanoyl Tyr lie tyrosine and isoleucine at R2 and R 3 , respectively a wide range of amino acid and other residues might be used for the mimetics or agonists (Family 1 and Families 2- 5, respectively) in the practice of embodiments of the invention at these other positions including, without limitation, tyrosine, cysteine, methionine, phenylalaine, aspartic acid, glutamic acid, histidine, tryptophan, lysine, leucine, valine, homocysteine, homoserine, and homophenyalanine

As of June 2026, tirzepatide is FDA-approved (Zepbound, Mounjaro) and CagriSema is not